These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 32758246)

  • 1. Barriers and motivators to participation and retention in HIV/HCV cohort studies among people who inject drugs: a community consultation in Iran.
    Mirzazadeh A; Hosseini-Hooshyar S; Shahesmaeili A; Bahramnejad A; Barshan A; Mousavian G; Najafi E; Sharifi H; Haghdoost AA; Briceno A; McFarland W; Page K
    Subst Abuse Treat Prev Policy; 2020 Aug; 15(1):56. PubMed ID: 32758246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishing trust in HIV/HCV research among people who inject drugs (PWID): Insights from empirical research.
    Abadie R; Goldenberg S; Welch-Lazoritz M; Fisher CB
    PLoS One; 2018; 13(12):e0208410. PubMed ID: 30517202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proportion and reasons for loss to follow-up in a cohort study of people who inject drugs to measure HIV and HCV incidence in Kerman, Iran.
    Mousavian G; Ghalekhani N; Tavakoli F; McFarland W; Shahesmaeili A; Sharafi H; Khezri M; Mehmandoost S; Zarei J; Sharifi H; Mirzazadeh A
    Subst Abuse Treat Prev Policy; 2021 Apr; 16(1):29. PubMed ID: 33794943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High variability of HIV and HCV seroprevalence and risk behaviours among people who inject drugs: results from a cross-sectional study using respondent-driven sampling in eight German cities (2011-14).
    Wenz B; Nielsen S; Gassowski M; Santos-Hövener C; Cai W; Ross RS; Bock CT; Ratsch BA; Kücherer C; Bannert N; Bremer V; Hamouda O; Marcus U; Zimmermann R;
    BMC Public Health; 2016 Sep; 16(1):927. PubMed ID: 27595567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Barriers and facilitators of HIV and hepatitis C care among people who inject drugs in Nairobi, Kenya: a qualitative study with peer educators.
    Ludwig-Barron NT; Guthrie BL; Mbogo L; Bukusi D; Sinkele W; Gitau E; Farquhar C; Monroe-Wise A
    Harm Reduct J; 2021 Dec; 18(1):133. PubMed ID: 34922548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integration of a geospatially targeted community-based testing approach with respondent-driven sampling to identify people who inject drugs living with HIV and HCV in Patti and Gorakhpur, India.
    Loeb TA; McFall AM; Srikrishnan AK; Anand S; Vasudevan CK; Mehta SH; Solomon SS
    Drug Alcohol Depend; 2023 Jun; 247():109874. PubMed ID: 37087926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 'Treat my whole person, not just my condition': qualitative explorations of hepatitis C care delivery preferences among people who inject drugs.
    Tsui JI; Barry MP; Austin EJ; Sweek EW; Tung E; Hansen RN; Ninburg M; Scott JD; Glick SN; Williams EC
    Addict Sci Clin Pract; 2021 Aug; 16(1):52. PubMed ID: 34384494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigating the sociodemographic and behavioural factors associated with hepatitis C virus testing amongst people who inject drugs in England, Wales and Northern Ireland: A quantitative cross-sectional analysis.
    Yuan JM; Croxford S; Viviani L; Emanuel E; Phipps E; Desai M
    Int J Drug Policy; 2022 Nov; 109():103821. PubMed ID: 35994940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Access to and use of health and social services among people who inject drugs in two urban areas of Mozambique, 2014: qualitative results from a formative assessment.
    Dengo-Baloi L; Boothe M; Semá Baltazar C; Sathane I; Langa DC; Condula M; Ricardo H; Inguane C; Teodoro E; Gouveia L; Raymond HF; Horth R
    BMC Public Health; 2020 Jun; 20(1):975. PubMed ID: 32571365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV- and hepatitis C-related risk behaviors among people who inject drugs in Uganda: implications for policy and programming.
    Baluku M; Wamala T; Muhangi D
    Harm Reduct J; 2019 Sep; 16(1):56. PubMed ID: 31481086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High prevalence of HIV, HBsAg and anti-HCV positivity among people who injected drugs: results of the first bio-behavioral survey using respondent-driven sampling in two urban areas in Mozambique.
    Semá Baltazar C; Horth R; Boothe M; Sathane I; Young P; Chitsondzo Langa D; Condula M; Ricardo H; Dengo Baloi L; Cummings B; Schaad N; Gouveia L; Teodoro E; Raymond HF
    BMC Infect Dis; 2019 Dec; 19(1):1022. PubMed ID: 31791273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C virus prevalence, determinants, and cascade of care among people who inject drugs in Iran.
    Khezri M; Mirzazadeh A; Shokoohi M; Sharafi H; Ghalekhani N; Tavakoli F; Mehmandoost S; Mousavian G; Imani M; Kakavand-Ghalehnoei R; Komasi A; Gouya MM; Haghdoost AA; McFarland W; Karamouzian M; Sharifi H
    Drug Alcohol Depend; 2023 Feb; 243():109751. PubMed ID: 36621200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An urgent need to scale-up injecting drug harm reduction services in Tanzania: prevalence of blood-borne viruses among drug users in Temeke District, Dar-es-Salaam, 2011.
    Bowring AL; Luhmann N; Pont S; Debaulieu C; Derozier S; Asouab F; Toufik A; van Gemert C; Dietze P; Stoove M
    Int J Drug Policy; 2013 Jan; 24(1):78-81. PubMed ID: 23036650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of peer support on testing, linkage to and engagement in HIV care for people who inject drugs in Indonesia: qualitative perspectives from a community-led study.
    Iryawan AR; Stoicescu C; Sjahrial F; Nio K; Dominich A
    Harm Reduct J; 2022 Feb; 19(1):16. PubMed ID: 35148776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Motivations, facilitators and barriers to accessing hepatitis C treatment among people who inject drugs in two South African cities.
    Versfeld A; McBride A; Scheibe A; Spearman CW
    Harm Reduct J; 2020 Jun; 17(1):39. PubMed ID: 32522210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An on-site community-based model for hepatitis C screening, diagnosis, and treatment among people who inject drugs in Kerman, Iran: The Rostam study.
    Mirzazadeh A; Hosseini-Hooshyar S; Shahesmaeili A; Sharafi H; Shafiei M; Zarei J; Mousavian G; Tavakoli F; Ghalekhani N; Shokoohi M; Khezri M; Mehmandoost S; Shojaei MR; Karamouzian M; Briceno A; Morris MD; Alavian SM; Haghdoost AA; Sharifi H; Page KA
    Int J Drug Policy; 2022 Apr; 102():103580. PubMed ID: 35074607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Injection cessation and relapse to injection and the associated factors among people who inject drugs in Iran: The Rostam study.
    Mehmandoost S; Mirzazadeh A; Karamouzian M; Khezri M; Sharafi H; Shahesmaeili A; Maghsoudi SH; Ghalekhani N; Tavakoli F; Bazrafshani MS; Shokoohi M; Aghaali N; Haghdoost AA; Sharifi H
    Subst Abuse Treat Prev Policy; 2023 Nov; 18(1):72. PubMed ID: 38031110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. M
    Martel-Laferrière V; Feaster DJ; Metsch LR; Schackman BR; Loignon C; Nosyk B; Tookes H; Behrends CN; Arruda N; Adigun O; Goyer ME; Kolber MA; Mary JF; Rodriguez AE; Yanez IG; Pan Y; Khemiri R; Gooden L; Sako A; Bruneau J
    Trials; 2022 Apr; 23(1):341. PubMed ID: 35461260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Homelessness, unstable housing, and risk of HIV and hepatitis C virus acquisition among people who inject drugs: a systematic review and meta-analysis.
    Arum C; Fraser H; Artenie AA; Bivegete S; Trickey A; Alary M; Astemborski J; Iversen J; Lim AG; MacGregor L; Morris M; Ong JJ; Platt L; Sack-Davis R; van Santen DK; Solomon SS; Sypsa V; Valencia J; Van Den Boom W; Walker JG; Ward Z; Stone J; Vickerman P;
    Lancet Public Health; 2021 May; 6(5):e309-e323. PubMed ID: 33780656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Awareness and willingness to use HIV self-testing among people who inject drugs in Iran.
    Khezri M; Goldmann E; Tavakoli F; Karamouzian M; Shokoohi M; Mehmandoost S; Ghalekhani N; Haghdoost AA; Des Jarlais D; Mirzazadeh A; Sharifi H
    Harm Reduct J; 2023 Oct; 20(1):145. PubMed ID: 37805505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.